Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-90
SponsorPeking Union Medical College Hospital

About this trial

This project anchors osteoporotic fractures, conduct registration and follow-up studies, and conduct prospective treatment studies. By registering for follow-up studies on osteoporotic fractures, it is planned to obtain epidemiological data through registration and follow-up studies; A prospective treatment study for patients with osteoporotic fractures is planned to explore effective treatment strategies through randomized controlled trials; To study biomarkers for osteoporotic refractures, we plan to establish a biomarker warning model through multi omics research; To study imaging biomarkers for osteoporotic refractures, a new imaging technology is proposed to establish an imaging omics warning model.

Eligibility criteria

Qualifiers

New brittle hip fractures;

New brittle vertebral fractures;

New other site fractures and/or total hip or neck of femur or L1-L4 T-value < -1.0;

Men or postmenopausal women;

Disqualifiers

bone metabolic diseases except for osteoporosis eg. a. (Osteogenesis Imperfecta, Paget's disease, Osteomalacia), b. Cushing's syndrome, c.hyperprolactinemia;

Having primary hyperparathyroidism or hypothyroidism;

Had or have osteomyelitis of the jaw or necrosis of the jaw;

GFR<30ml/min/1.73m2;

Trial design

Treatments tested in this trial

  • Denosumab
  • Teriparatide

Treatment groups

2,478 Participants
are divided into 2 treatment groups

Locations

58
Beijing Friendship Hospital, Capital Medical University Beijing China
Beijing Hospital Beijing China
Beijing Pinggu Hospital Beijing China
Beijing Shijingshan Hospital Beijing China

Sponsors and collaborators

Peking Union Medical College Hospital

Lead sponsor